Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016003
Filing Date
2025-06-06
Accepted
2025-06-06 16:47:48
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06062025_080640.html 4  
1 form4-06062025_080640.xml 4 3348
  Complete submission text file 0001415889-25-016003.txt   4823
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Issuer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
KNOBELMAN DEBORAH (Reporting) CIK: 0001931509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39592 | Film No.: 251031406